齐鲁晚报·齐鲁壹点 张志恒 综合中华网 泰山财经 登录新浪财经APP 搜索【信披】查看更多考评等级 近日，威海百合生物技术股份有限公司（以下简称"百合股份"，股票代码：603102）与山东海莱云视股份有限公司（以下简称"海莱云 视"）之间的纠纷出现在大众面前。这一事件不仅涉及复杂的商业利益纠葛，更因疑似商业贿赂问题，给企业的市场形象及未来发展前景 蒙上阴影。 据了解，此次纠纷的源头，来源于一则废弃的合同。2020年12月，百合股份与海莱云视签订代工合同，生产燕麦麸等代餐产品。2021年1 月和3月时，百合股份依照订单完成了生产任务。但自2021年3月底起，海莱云视便停止下达新的生产指令。直到2年后，2024年百合股份 突然告知海莱云视，此前为该合同准备的一批原料已过期报废，并要求海莱云视承担相应损失，法院也曾建议双方协商，但百合股份要 价过高，双方协商无果后最终对簿公堂。 在诉讼推进过程中，案件出现了戏剧性的转折。据媒体报道，海莱云视的代理律师在审查百合股份提交的证据时，意外发现双方在燕麦 麸SC类代餐产品代加工合作的评审环节，存在一项给予甲方采购人员每盒0.6元费用的记录。从百合股份内部的合同评审表来看，副 ...

Core Insights - NativePath has launched a new activated charcoal product featuring a 1,000 mg coconut-shell formula aimed at enhancing daily gut health and detoxification [1][2][3] - The product is manufactured in a GMP-certified facility and undergoes third-party testing to ensure potency and sourcing integrity [2][19] Product Features - Each capsule contains 1,000 mg of high-adsorption activated charcoal derived from raw coconut shells, optimized for microporous density and surface area [1][5] - The activated charcoal is processed at high temperatures in an oxygen-restricted environment, creating a dense network of micropores for effective binding of toxins and impurities [4][8] - The formula is free from synthetic fillers, binders, preservatives, or artificial ingredients, aligning with clean-label standards [5][17] Ingredient Science - Activated charcoal functions through adsorption, binding unwanted materials in the digestive tract for natural elimination [3][7] - The coconut shell charcoal used in NativePath's product is noted for its superior micropore density and adsorption capacity compared to hardwood and bone charcoals [10][11] Market Trends - There is a growing consumer interest in activated charcoal for digestive health, particularly among individuals aged 40 and older seeking non-pharmaceutical solutions [13][15] - Keywords related to activated charcoal have seen increased search interest, indicating a trend towards clean-label detox solutions [14][22] Consumer Applications - The product is designed for various wellness scenarios, including bloating relief, gut reset, and support against environmental toxins [20][25] - NativePath's activated charcoal is intended for regular use, with recommendations to take it away from food and medications to avoid interactions [26][28] Company Overview - NativePath is a wellness brand focused on clean-label dietary supplements, emphasizing ingredient transparency and third-party testing [29][30] - The company aims to meet the rising demand for trustworthy supplements that align with modern health standards [30]

2024年我国维生素及膳食补充剂VDS市场规模2323亿同比+4%，对比美国，我国各年龄段保健品渗透率 均较美国具备提升空间，后续随中青年培养保健品消费习惯及老龄化，市场具备长期成长性。保健品成 分、作用部位众多，需求较为分散，因此格局分散，2024年我国VDS市场公司口径CR3为22%，TOP3 汤臣倍健、安利、H&H零售额均超百亿。与美妆类似，保健品高毛利率、高营销费用率，功效化阶段 更早、龙头烈度更低，当下处于变革新阶段。 国泰海通主要观点如下： 千亿保健品市场，有望随新人群、新需求扩容 国泰海通发布研报称，与美妆类似，保健品高毛利率、高营销费用率，功效化阶段更早、龙头烈度更 低，当下处于变革新阶段。新渠道、新客群有望催化保健品功效性新需求，行业迎来变革新机遇，看好 产品创新能力突出叠加强运营的品牌跑出。推荐代运营转型自主品牌孵化、斐萃品牌放量的若羽臣 （003010）(003010.SZ)，关注汤臣倍健（300146）(300146.SZ)的调整改善，相关标的：金达威 （002626）(002626.SZ)、H&H国际控股(01112)、仙乐健康（300791）(300791.SZ)、百合股份 （60 ...

二是警惕话术诱导陷阱。私域直播间常通过封闭场景实施情感营销，如以"亲情关怀""健康咨询""专家 讲座"等名义，违规使用"包治百病""根治慢性病""替代药物治疗"等用语，或通过宣称"专家推荐""祖传 秘方"等进行虚假权威背书，利用"限时秒杀""最后优惠"制造消费焦虑，或以"无效退款""无毒副作用"等 承诺欺骗消费者。 三是警惕资质信息盲区。购买产品前应查验直播间是否公示营业执照、食品经营许可证或药品经营许可 证，核查保健食品是否标注"蓝帽子"标志及批准文号，核查药品是否具备"国药准字"批号（可通过国家 药品监管局官网查询https://www.nmpa.gov.cn）。 四是选择正规平台进行消费。购买商品或服务时，建议选择信誉良好、资质齐全的正规平台和商家进行 消费，警惕通过拉群进私域直播间、临时链接等非正规渠道进行交易。交易时注意保存直播录屏、商品 链接、支付凭证、客服聊天记录等信息，要求开具正规发票或者收据。签收易碎、贵重物品时，需当场 查验外观及基本功能，必要时全程录像。 五是依法维护自身权益。保健食品仅具调节机体功能，不能替代药物治疗疾病；身体不适请至正规医疗 机构就诊，勿因轻信直播宣传延误治疗。如果发 ...

Core-Mark National Authorization, Walmart Canada Breakthrough, and Key Regional Wins Highlight Rapid Growth in Functional Beverage and Supplement Categories WESTBROOK, Maine, June 30, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) ("Synergy" or the "Company"), a fast-growing consumer health and wellness company, today announced a major wave of North American retail and distribution gains across both its supplement and functional beverage portfolios. These wins represent the Company's most signifi ...

Core Insights - Yerbaé Brands Corp. has successfully completed a business combination with Safety Shot, Inc., where Safety Shot acquired all outstanding shares of Yerbaé [1][2] - The transaction was executed through a court-approved plan of arrangement, resulting in Safety Shot shareholders owning approximately 81.64% of the combined company, while former Yerbaé shareholders own about 18.36% [2][3] Transaction Overview - Under the arrangement agreement dated January 7, 2025, Safety Shot acquired all Yerbaé shares, with each Yerbaé shareholder receiving 0.2918 of a Safety Shot share for each Yerbaé share held [3] - The total number of Safety Shot shares issued in the transaction was 19,881,948 [2] - Yerbaé shares will be delisted from the TSX Venture Exchange and OTCQX effective June 30, 2025 [3] Shareholder Information - Yerbaé shareholders with physical share certificates must submit a Letter of Transmittal to receive their Safety Shot shares [4] - For shareholders holding shares in book-entry form or brokerage accounts, the exchange of shares is automatic [5] Company Profiles - Safety Shot, Inc. specializes in wellness and dietary supplements, notably developing Sure Shot, a patented product that lowers blood alcohol content while enhancing clarity and energy [6] - Yerbaé Brands Corp. produces plant-based energy beverages that are zero calorie, zero sugar, and cater to various dietary preferences, aiming to disrupt the energy beverage market [7] Advisory Information - Maxim Group LLC acted as the exclusive financial advisor to Safety Shot during the merger [8] - Legal counsel for Yerbaé was provided by Cozen O'Connor LLP, while Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. served as legal counsel for Safety Shot [9]

FEEL THE POWER Investor Presentation | November 2024 1 SAFE HARBOR STATEMENTS Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements regarding the Company's future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements may include, but are not limited to, statements relating to our objectives, plans, strategies and financial results, including expected impr ...

Core Viewpoint - Nature's Sunshine Products, Inc. is conducting a secondary public offering of up to 2,854,607 shares at a price of $12.00 per share, with the offering expected to close on June 27, 2025 [1][2]. Group 1: Offering Details - The Selling Stockholder, Fosun Pharma USA, Inc., will receive all net proceeds from the offering, while Nature's Sunshine will not sell any shares or receive any proceeds [2]. - The Company has agreed to potentially purchase up to $15.0 million of its common stock from the underwriters as part of its share repurchase program, but there is no guarantee that any shares will be purchased [3]. - D.A. Davidson & Co. is acting as the sole book-running manager for the offering, which is made under a shelf registration statement filed with the SEC [4]. Group 2: Company Background - Nature's Sunshine Products is a leading manufacturer of herbal and nutritional supplements, distributing products in over 40 countries and ensuring high quality through its own manufacturing facilities [8].

Core Insights - Prenetics Global Limited announced a partnership between its premium supplements brand IM8 and world No. 1 tennis player Aryna Sabalenka, who becomes the brand's global ambassador and shareholder [1][6][12] - This partnership is significant as it marks the first endorsement of a supplement brand by Sabalenka, who has reported substantial benefits from using IM8's Daily Ultimate Essentials [3][4][5] Company Overview - Prenetics is a leading consumer health sciences company listed on NASDAQ under the ticker PRE, focusing on advancing consumer health through various initiatives, including IM8 [10] - IM8, co-founded by David Beckham, has rapidly grown to generate over US$50 million in Annual Recurring Revenue within just six months of its launch [6][8] - IM8 has built a loyal customer base of over 60,000 users, delivering more than 5 million servings of its products [6][8] Product Details - IM8's flagship product, Daily Ultimate Essentials, is designed to replace 16 different supplements with a single, NSF Certified for Sport® powder supplement [11] - The product is non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors, or sweeteners [11] Market Context - The partnership comes at a time when supplement safety and quality are critical issues in professional sports, with IM8's NSF Certified for Sport® designation ensuring rigorous testing for prohibited substances [7] - IM8's revenue growth trajectory exceeds typical benchmarks for successful supplement launches by 500%, indicating strong market demand and acceptance [8]

Core Insights - Prenetics Global Limited announced a partnership between its premium supplements brand IM8 and world No. 1 tennis player Aryna Sabalenka, who becomes the brand's global ambassador and shareholder [1][6][12] - This partnership is significant as it marks the first endorsement of a supplement brand by Sabalenka, who has reported substantial benefits from using IM8's Daily Ultimate Essentials [3][4][6] Company Overview - Prenetics is a leading consumer health sciences company listed on NASDAQ under the ticker PRE, focusing on advancing consumer health through innovative products [10] - IM8, co-founded by David Beckham, is a rapidly growing health and wellness brand that has achieved over US$50 million in Annual Recurring Revenue within six months of its launch [6][8][11] Product Details - IM8's flagship product, Daily Ultimate Essentials, is designed to replace 16 different supplements with a single, NSF Certified for Sport® powder supplement, ensuring safety and efficacy for athletes [11][12] - The product has gained a loyal customer base of over 60,000 users, who have consumed more than 5 million servings [6][8] Market Position - IM8 is recognized as one of the fastest-growing supplement brands globally, with its revenue velocity exceeding typical benchmarks for successful launches by 500% [8] - The partnership with Sabalenka comes at a time when supplement safety and quality are critical issues in professional sports, highlighting the importance of IM8's NSF certification [7][8] Athlete Endorsement - Aryna Sabalenka's personal experience with IM8 has led her to not only endorse the brand but also invest in it, reflecting her confidence in the product's quality and effectiveness [5][7] - The collaboration emphasizes the alignment of Sabalenka's values of athletic excellence and professionalism with IM8's commitment to quality and innovation [7][9]